These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 8188579)

  • 41. Conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
    Poschet JF; Boucher JC; Firoved AM; Deretic V
    Methods Enzymol; 2001; 336():65-76. PubMed ID: 11398420
    [No Abstract]   [Full Text] [Related]  

  • 42. Small Noncoding Regulatory RNAs from
    Pita T; Feliciano JR; Leitão JH
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pseudomonas aeruginosa infection and cystic fibrosis.
    Kato K; Takayama T
    Lancet; 2002 Jan; 359(9302):262. PubMed ID: 11812595
    [No Abstract]   [Full Text] [Related]  

  • 44. Colonisation of cystic fibrosis patients by non-mucoid Pseudomonas aeruginosa--characterisation of the alginate from mucoid variants.
    Tatnell PJ; Russell NJ; Govan JR; Gacesa P
    Biochem Soc Trans; 1996 Aug; 24(3):406S. PubMed ID: 8878950
    [No Abstract]   [Full Text] [Related]  

  • 45. Pseudomonas infections in cystic fibrosis.
    George RH
    Arch Dis Child; 1987 May; 62(5):438-9. PubMed ID: 3111389
    [No Abstract]   [Full Text] [Related]  

  • 46. Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment.
    Fernández-Barat L; Ciofu O; Kragh KN; Pressler T; Johansen U; Motos A; Torres A; Hoiby N
    J Cyst Fibros; 2017 Mar; 16(2):222-229. PubMed ID: 27651273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.
    Coleman FT; Mueschenborn S; Meluleni G; Ray C; Carey VJ; Vargas SO; Cannon CL; Ausubel FM; Pier GB
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1949-54. PubMed ID: 12578988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients.
    Lee B; Schjerling CK; Kirkby N; Hoffmann N; Borup R; Molin S; Høiby N; Ciofu O
    APMIS; 2011 Apr; 119(4-5):263-74. PubMed ID: 21492226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of D-amino acid dehydrogenase on virulence factor production by a Pseudomonas aeruginosa.
    Oliver KE; Silo-Suh L
    Can J Microbiol; 2013 Sep; 59(9):598-603. PubMed ID: 24011342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa.
    Ernst RK; Yi EC; Guo L; Lim KB; Burns JL; Hackett M; Miller SI
    Science; 1999 Nov; 286(5444):1561-5. PubMed ID: 10567263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basic science for the chest physician: Pseudomonas aeruginosa and the cystic fibrosis airway.
    Williams HD; Davies JC
    Thorax; 2012 May; 67(5):465-7. PubMed ID: 22382597
    [No Abstract]   [Full Text] [Related]  

  • 52. Multi-resistant Pseudomonas aeruginosa ST235 in cystic fibrosis.
    Lee AC; Jones AL
    Paediatr Respir Rev; 2018 Jun; 27():18-20. PubMed ID: 29914746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treating resistant Pseudomonas aeruginosa lung disease in young children with cystic fibrosis.
    Lim SZP; Fitzgerald DA
    Paediatr Respir Rev; 2018 Jun; 27():33-36. PubMed ID: 29033215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections.
    Nguyen D; Singh PK
    Proc Natl Acad Sci U S A; 2006 May; 103(22):8305-6. PubMed ID: 16717189
    [No Abstract]   [Full Text] [Related]  

  • 55. Pseudomonas aeruginosa Proteome under Hypoxic Stress Conditions Mimicking the Cystic Fibrosis Lung.
    Kamath KS; Krisp C; Chick J; Pascovici D; Gygi SP; Molloy MP
    J Proteome Res; 2017 Oct; 16(10):3917-3928. PubMed ID: 28832155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The alternative sigma factor AlgT represses Pseudomonas aeruginosa flagellum biosynthesis by inhibiting expression of fleQ.
    Tart AH; Wolfgang MC; Wozniak DJ
    J Bacteriol; 2005 Dec; 187(23):7955-62. PubMed ID: 16291668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The deletion of TonB-dependent receptor genes is part of the genome reduction process that occurs during adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung.
    Dingemans J; Ye L; Hildebrand F; Tontodonati F; Craggs M; Bilocq F; De Vos D; Crabbé A; Van Houdt R; Malfroot A; Cornelis P
    Pathog Dis; 2014 Jun; 71(1):26-38. PubMed ID: 24659602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of pyocyanin in Pseudomonas aeruginosa infection.
    Lau GW; Hassett DJ; Ran H; Kong F
    Trends Mol Med; 2004 Dec; 10(12):599-606. PubMed ID: 15567330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes.
    Anuj SN; Whiley DM; Kidd TJ; Bell SC; Wainwright CE; Nissen MD; Sloots TP
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):127-31. PubMed ID: 19026507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.
    Rieber N; Brand A; Hector A; Graepler-Mainka U; Ost M; Schäfer I; Wecker I; Neri D; Wirth A; Mays L; Zundel S; Fuchs J; Handgretinger R; Stern M; Hogardt M; Döring G; Riethmüller J; Kormann M; Hartl D
    J Immunol; 2013 Feb; 190(3):1276-84. PubMed ID: 23277486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.